Under the Microscope: Trends in Life Science Investments and Exits Online SeminarSeptember 07, 2010 Posted by: Dave KrimmSVB Analytics' Web seminar focuses on trends in the Life Science sector, including venture capital financing, M&A, and IPO activity. In this free replay of the seminar, you will hear a variety of viewpoints from our expert panel of venture capitalists who have investment experience in the Life Science sector, as well as valuation and research professionals from SVB.
See the Web seminar replay [PLAYBACK]
Read the presentation [PDF]
Read the article
Read the Q&A Summary [PDF]
Speakers:
Albert Cha, MD - Managing Partner, Vivo Ventures
Mark-Henri Galletti - Managing Director, Longitude Capital
David Marr - Associate, SVB Analytics
Dan Zaelit- Research Associate, SVB Analytics
Jonathan Norris - Managing Director, Silicon Valley Bank (moderator)
Dave Krimm - Head of Strategy and Product Management, SVB Analytics
Among the topics discussed:
A Venture Capital perspective on valuing new deals and exit values in the Life Science sectorLife Science exit data including exit multiples, and time- and capital-to-exitSVB Analytics' perspective on Life Science valuationsOperating Performance: trends in revenue, expense, cash position, and liquidity values
Read More